A review found that studies can map fats in human brain tissue, but a complete map is still missing.
The review included 34 studies of fats in human brain tissue. The studies looked at where different fats appeared in brain tissue. MS was among the most studied conditions, along with Alzheimer's disease and schizophrenia. Some findings were consistent across studies, while others differed. The researchers found gaps in how studies were done and said a complete brain fat map is still missing.
This review examined studies of human brain tissue, including tissue from people with MS. It also covered people with other brain disorders and people without them. The findings show what researchers currently know about where fats appear in brain tissue. Their location may help researchers link changes in fats to specific areas or damaged spots. The review is relevant to MS research, but it was not limited to MS.
You should know this was a review of 34 published studies, not a new test of a treatment. The studies asked different questions and used different methods, which makes their findings hard to compare. You cannot tell from this review whether mapping brain fats will improve MS care.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More11/1/2026
In a study of 294 pregnancies, MS flare-ups were uncommon after pausing two treatments. Learn what t
Read More10/14/2026
Exercise may help people use less energy while walking, but evidence for MS is limited. See what thi
Read More10/14/2026
A review of cell-by-cell studies finds clues about immune activity in MS, but says more testing is n
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Molecular psychiatry often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.